Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types.

Saved in:
Bibliographic Details
Title: Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types.
Authors: Bosma AL; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., Ouwerkerk W; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.; NHRIS, National Heart Centre Singapore, Singapore., Heidema MJ; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., Prieto-Merino D; Faculty of Medicine, Universidad de Alcalá, Madrid, Spain.; Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's & St Thomas' NHS Foundation Trust and King's College London, London, UK., Ardern-Jones MR; Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Department of Dermatology, University Hospitals NHS Foundation Trust, Southampton, UK., Beattie P; Department of Dermatology, Royal Hospital for Children NHS Trust, Glasgow, UK., Brown SJ; Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK., Ingram JR; Department of Dermatology, Division of Infection & Immunity, Cardiff University, Cardiff, UK., Irvine AD; Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland., Ogg G; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Patel P; Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's & St Thomas' NHS Foundation Trust and King's College London, London, UK., Reynolds NJ; Department of Dermatology, Institute of Cellular Medicine, Medical School, Newcastle University, Royal Victoria Infirmary and NIHR Newcastle Biomedical Research Centre Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Hearn RMR; Department of Dermatology & Photobiology, Ninewells Hospital and Medical School, Dundee, UK., Wan M; Pharmacy Department, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Institute of Pharmaceutical Science, King's College London, London, UK., Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, NIHR Manchester Biomedical 17 Research Centre, University of Manchester, Manchester, UK., Woolf RT; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Hyseni AM; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., Gerbens LAA; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., Spuls PI; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., Flohr C; Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's & St Thomas' NHS Foundation Trust and King's College London, London, UK., Middelkamp-Hup MA; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
Corporate Authors: TREAT NL registry and UK-Irish A-STAR Study Groups
Source: JAAD international [JAAD Int] 2022 Oct 10; Vol. 10, pp. 14-24. Date of Electronic Publication: 2022 Oct 10 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774762 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3287 (Electronic) Linking ISSN: 26663287 NLM ISO Abbreviation: JAAD Int Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-3287
DOI:10.1016/j.jdin.2022.09.006